18 Biggest Mid-Day Gainers For Wednesday - Athersys Inc (OTC:ATHX)

Tonix Pharmaceuticals Holding Corp. TNXP shares jumped 46.9 percent to $6.08. Tonix Pharma will present the FDA Breakthrough Therapy-designated PTSD program at The MicroCap Conference on April 4, 2017.
Innocoll Holdings PLC INNL shares climbed 26.8 percent to $1.37 after the company reported that it has received formal FDA Type A Meeting minutes related to XARACOLL NDA.
Vertex Pharmaceuticals Incorporated VRTX shares surged 23 percent to $110.31 after the company disclosed that two Phase 3 studies of the tezacaftor/ivacaftor combo treatment for CF met primary endpoints. BMO Capital upgraded Vertex Pharma from Market Perform to Outperform.
Exar Corporation EXAR shares climbed 22.6 percent to $13.02 after the company agreed to be acquired by MaxLinear, Inc. MXL for $13 per share in cash.
Sigma Labs Inc SGLB shares gained 18.6 percent to $3.57 after the company disclosed that it has entered into a long term non-exclusive commercial agreement with Additive Industries for PrintRite3D®.
XCel Brands Inc XELB shares rose 17.5 percent to $2.35.
Athersys, Inc. ATHX surged 16.5 percent to $1.38. William Blair initiated coverage on Athersys with an Outperform rating.
Vistagen Therapeutics Inc VTGN shares gained 13.6 percent to $2.09 as the company disclosed that it has received a European Patent Office notice of intent to grant patent for AV-101.
RH RH rose 12.3 percent to $42.66 as the company reported upbeat results for its fourth quarter.
Glassbridge Enterprises Inc GLA shares gained 11.9 percent to $4.90.
Quad/Graphics, Inc. QUAD climbed 11 percent to $24.66. Macquarie upgraded Quad/Graphics from Neutral to Outperform.
Eldorado Gold Corp (USA) EGO rose 10 percent to $3.47. Canaccord Genuity upgraded Eldorado Gold from Hold to Buy.
Verint Systems Inc. VRNT shares surged 9.6 percent to $43.35 after the company posted stronger-than-expected earnings for its fourth quarter.
Egalet Corp EGLT shares rose 7.2 percent to $5.19. Egalet disclosed that its challenge to the FDA for MorphaBond exclusivity is still being considered.
Sangamo Therapeutics Inc SGMO gained 5 percent to $4.25 after the company reported the presentation of new data showing 'significant reduction of tau mRNA, tau protein expression using ZFP-TF-mediated gene regulation technology.'
Sonoma Pharmaceuticals Inc SNOA shares gained 4.5 percent to $7.40 after the company reported the FDA clearance of Loyon Skin Descaler.
Fortinet Inc FTNT rose 4.3 percent to $38.14. Baird upgraded Fortinet from Neutral to Outperform.
S&W Seed Company SANW gained 3.3 percent to $4.65. B. Riley initiated coverage on S&W Seed with a Buy rating.

Market News and Data brought to you by Benzinga APIs